MS Pharma Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
2,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
MS Pharma General Information
Description
Operator of a pharmaceutical company specializing in the development, production and distribution of generic and specialty medicines. The company's generic medicines are used for injectables and medication for various chronic diseases such as cardiovascular, central nervous system and respiratory diseases providing improved therapeutic entities with differentiated technologies, enabling its patients with modified release formulations and other non-conventional dosage forms with more convenience, adherence, efficiency, safety and sustainability.
Contact Information
Website
www.mspharma.com(Operating Subsidiary)
Corporate Office
- Zahran Plaza Building, 7th Circle
- P.O Box: 142904
- Amman 11844
- Jordan
Corporate Office
- Zahran Plaza Building, 7th Circle
- P.O Box: 142904
- Amman 11844
- Jordan
MS Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MS Pharma Comparisons
Industry
Financing
Details
MS Pharma Competitors (49)
One of MS Pharma’s 49 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Neumentum | Venture Capital-Backed | Summit, NJ | ||||
| Doc Generici | Private Equity-Backed | Milan, Italy | ||||
| Sanochemia Pharmazeutika | Corporation | Neufeld an der Leitha, Austria | ||||
| Landsteiner Scientific | Formerly PE-Backed | Toluca, Mexico |
MS Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MS Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MS Pharma Investments (1)
MS Pharma’s most recent deal was a Buyout/LBO with Genepharm (Pharmaceuticals). The deal was made on 15-Apr-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Genepharm (Pharmaceuticals) | 15-Apr-2019 | Buyout/LBO | Pharmaceuticals |
MS Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Genepharm (Pharmaceuticals) | Pallini, Greece | 1967 |
MS Pharma FAQs
-
When was MS Pharma founded?
MS Pharma was founded in 1989.
-
Where is MS Pharma headquartered?
MS Pharma is headquartered in Amman, Jordan.
-
What is the size of MS Pharma?
MS Pharma has 2,000 total employees.
-
What industry is MS Pharma in?
MS Pharma’s primary industry is Pharmaceuticals.
-
Is MS Pharma a private or public company?
MS Pharma is a Private company.
-
What is MS Pharma’s current revenue?
The current revenue for MS Pharma is .
-
How much funding has MS Pharma raised over time?
MS Pharma has raised $95M.
-
Who are MS Pharma’s investors?
European Bank for Reconstruction and Development and International Finance Corporation have invested in MS Pharma.
-
Who are MS Pharma’s competitors?
The Zambon Group, Neumentum, Doc Generici, Sanochemia Pharmazeutika, and Landsteiner Scientific are some of the 49 competitors of MS Pharma.
-
When was MS Pharma acquired?
MS Pharma was acquired on 27-Mar-2023.
-
Who acquired MS Pharma?
MS Pharma was acquired by Neopharm Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
